Created at	Source	Raw Value	Validated value
April 21, 2021, 2 a.m.	irct	Cancer patients undergoing chemotherapy Patients with immunodeficiency diseases receiving immunomodulators Patients with uncontrolled heart, kidney or liver failure Women who are pregnant or breastfeeding Patients with low level of consciousness who are not able to inhale the spray	Cancer patients undergoing chemotherapy Patients with immunodeficiency diseases receiving immunomodulators Patients with uncontrolled heart, kidney or liver failure Women who are pregnant or breastfeeding Patients with low level of consciousness who are not able to inhale the spray